The Plux sensors will help researchers expand multimodal data acquisition to include respiration signals.

The firms said the sensors, which will be on the iMotions platform at the end of the first quarter of 2024, will help reveal feelings of excitement, happiness, anger, anxiety, stress and sadness in research participants.

Founded in 2005 and headquartered in Copenhagen, iMotions is a software-as-a-service (SaaS) company that runs a human behaviour software platform.

Plux Biosignals was created in 2007 and focuses on biosignals monitoring technologies, such as wearable body sensors such as electromyography (EMG), electrocardiography (ECG), respiration and accelerometers, combined with biosignals monitoring and acquisition software.

Peter Hartzbech, chief executive at iMotions, said: “Understanding human behaviour and its implications is critical for our customers – whether they’re researching the human condition or making major decisions about products and services.

“We are here to help them stay ahead by continuing to evolve our platform to meet the multimodal, multi-dimensional research needs of today and tomorrow.”

Rita Cristovão, chief executive at Plux Biosignals, said: “The integration of Plux Biosignals sensors into the iMotions platform marks a significant step in our journey to advance human behaviour research.

“Our collaboration goes beyond a simple technological union; it’s a combination of insights and expertise, focusing on improving our understanding of human physiology and psychology.”